Levels of Matrix-Degrading Enzymes and Lubricin in Patients With Degenerative Joint Disease Requiring Arthroplasty
Christopher Wanderling(University of Rochester), William Hopkinson(Loyola University Medical Center), Stephen Statz(Loyola University Chicago), Nil Güler(Loyola University Medical Center), Debra Hoppensteadt(Brigham and Women's Hospital), D. Schmitt(Loyola University Medical Center), Elissa S. Davis(Loyola University Medical Center), Jeffrey Liles(Loyola University Chicago), Jawed Fareed(Loyola University Chicago)
Cited by 9
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
|JAMA|2019|370
A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*
|Critical Care Medicine|2013|322
Nailfold Capillary Abnormalities in Primary Open-Angle Glaucoma: A Multisite Study
|Investigative Ophthalmology & Visual Science|2015|38
Recent Advances in Surgical Simulation For Resident Education
|Current Urology Reports|2023|30